<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01867554</url>
  </required_header>
  <id_info>
    <org_study_id>C12-06</org_study_id>
    <secondary_id>2012-A00936-37</secondary_id>
    <nct_id>NCT01867554</nct_id>
  </id_info>
  <brief_title>Research and Characterization of New Genes Involved in Intellectual Disability</brief_title>
  <acronym>GeneDefi</acronym>
  <official_title>Recherche et caractérisation de Nouveaux gènes impliqués Dans la déficience Intellectuelle.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intellectual disability (ID) occurs in 2 to 3 % of the general population but the cause is
      identified only in 30 to 60% of cases.

      The purpose of this study is to indentify genes involved in ID with new genetics tools
      (SNP-arrays, next generation sequencing...) and establish genotype-phenotype correlations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with genetic cause identified</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants for which the causative gene of intellectual disability will be identified and number of genes involved in intellectual disability identified with new technologies including microarray and next generation sequencing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>genotype-phenotype correlations</measure>
    <time_frame>genotype-phenotype correlations (according to the genes identified in a period of 5 years)</time_frame>
    <description>Explore genotype-phenotype correlations when a new gene involved in intellectual disability will be identified</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">8500</enrollment>
  <condition>Intellectual Disability</condition>
  <arm_group>
    <arm_group_label>Intellectual disability</arm_group_label>
    <description>patients with intellectual disability or psycho-motor retardation and their parents and sibs (affected or not)</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>gene analysis</intervention_name>
    <description>gene analysis</description>
    <arm_group_label>Intellectual disability</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA RNA Plasma Urines
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  2500 patients with intellectuel disability

          -  5000 parents or unaffected sibs

          -  1000 affected sibs
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  for the patients: Clinical diagnosis of intellectual disbility

          -  for the unaffected sibs: to be aged at least 3 years

          -  informed consent

        Exclusion Criteria:

          -  absence of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis Brice, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Delphine Heron, MD</last_name>
    <phone>+33 1 42 16 13 47</phone>
    <email>delphine.heron@psl.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CRICM - UPMC/Inserm UMR_S975/CNRS UMR7225, Groupe Hospitalier de la Pitié-Salpêtrière,</name>
      <address>
        <city>Paris</city>
        <zip>750013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine Heron, MD</last_name>
      <phone>+33 1 42 16 13 47</phone>
      <email>delphine.heron@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Delphine Heron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Nava C, Lamari F, Héron D, Mignot C, Rastetter A, Keren B, Cohen D, Faudet A, Bouteiller D, Gilleron M, Jacquette A, Whalen S, Afenjar A, Périsse D, Laurent C, Dupuits C, Gautier C, Gérard M, Huguet G, Caillet S, Leheup B, Leboyer M, Gillberg C, Delorme R, Bourgeron T, Brice A, Depienne C. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry. 2012 Oct 23;2:e179. doi: 10.1038/tp.2012.102.</citation>
    <PMID>23092983</PMID>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2013</study_first_submitted>
  <study_first_submitted_qc>June 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2013</study_first_posted>
  <last_update_submitted>December 6, 2016</last_update_submitted>
  <last_update_submitted_qc>December 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intellectual disability</keyword>
  <keyword>Autism spectrum disorders</keyword>
  <keyword>gene</keyword>
  <keyword>Next generation sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intellectual Disability</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

